Heran CL - Search Results

1

Carbopol-mediated paracellular transport enhancement in Calu-3 cell layers.

Li L, Mathias NR, Heran CL, Moench P, Wall DA, Smith RL. Li L, et al. Among authors: heran cl. J Pharm Sci. 2006 Feb;95(2):326-35. doi: 10.1002/jps.20541. J Pharm Sci. 2006. PMID: 16374869

2

pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.

Zhou R, Moench P, Heran C, Lu X, Mathias N, Faria TN, Wall DA, Hussain MA, Smith RL, Sun D. Zhou R, et al. Pharm Res. 2005 Feb;22(2):188-92. doi: 10.1007/s11095-004-1185-3. Pharm Res. 2005. PMID: 15783065

3

Rat nasal lavage biomarkers to assess preclinical irritation potential of nasal drug formulations and excipients.

Mathias NR, Moench P, Heran C, Hussain MA, Smith RL. Mathias NR, et al. J Pharm Sci. 2009 Feb;98(2):495-502. doi: 10.1002/jps.21449. J Pharm Sci. 2009. PMID: 18506818

4

A rabbit model for sublingual drug delivery: comparison with human pharmacokinetic studies of propranolol, verapamil and captopril.

Dali MM, Moench PA, Mathias NR, Stetsko PI, Heran CL, Smith RL. Dali MM, et al. Among authors: heran cl. J Pharm Sci. 2006 Jan;95(1):37-44. doi: 10.1002/jps.20312. J Pharm Sci. 2006. PMID: 16307454

5

The effect of anesthesia on the pharmacokinetics of sublingually administered verapamil in rabbits.

Moench PA, Heran CL, Stetsko PI, Mathias NR, Wall DA, Hussain MA, Smith RL. Moench PA, et al. Among authors: heran cl. J Pharm Sci. 2003 Sep;92(9):1735-8. doi: 10.1002/jps.10436. J Pharm Sci. 2003. PMID: 12949993 No abstract available.

6

Low-molecular-weight heparin (fragmin) and thrombin active-site inhibitor (argatroban) compared in experimental arterial and venous thrombosis and bleeding time.

Schumacher WA, Heran CL, Steinbacher TE. Schumacher WA, et al. Among authors: heran cl. J Cardiovasc Pharmacol. 1996 Jul;28(1):19-25. doi: 10.1097/00005344-199607000-00004. J Cardiovasc Pharmacol. 1996. PMID: 8797131

7

Sensitivity of experimental venous and arterial thrombosis and bleeding to ancrod-induced defibrinogenation.

Schumacher WA, Heran CL, Steinbacher TE. Schumacher WA, et al. Among authors: heran cl. Thromb Res. 1996 Jan 15;81(2):187-94. doi: 10.1016/0049-3848(95)00235-9. Thromb Res. 1996. PMID: 8822133

8

Effects of antithrombotic drugs in a rat model of aspirin-insensitive arterial thrombosis.

Schumacher WA, Steinbacher TE, Heran CL, Megill JR, Durham SK. Schumacher WA, et al. Among authors: heran cl. Thromb Haemost. 1993 May 3;69(5):509-14. Thromb Haemost. 1993. PMID: 8322273

9

Antithrombotic effects of the thromboxane A2 antagonist, SQ 28,668, in vitro and in the coronary circulation in vivo.

Ogletree ML, Harris DN, Heran CL, Phillips MB, Michel IM, Goldenberg HJ. Ogletree ML, et al. Among authors: heran cl. Eicosanoids. 1988;1(2):85-91. Eicosanoids. 1988. PMID: 2856188

10

Effect of thromboxane receptor antagonists on venous thrombosis in rats.

Schumacher WA, Heran CL. Schumacher WA, et al. Among authors: heran cl. J Pharmacol Exp Ther. 1989 Mar;248(3):1109-15. J Pharmacol Exp Ther. 1989. PMID: 2522985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters